Angels Angle In Biotech
Executive Summary
Biotechnology hasn't traditionally been an area of great interest to angel investors, the well-off individuals who invest only their own money in startups.
You may also be interested in...
Stimulus Plans For Japan's Life Sciences Industries May Not Address Main Challenge - Bio Japan Conference
YOKOHAMA, Japan - Government agencies will initiate a plan in June 2011 to jumpstart Japan's lagging bioventure market, but government officials seem wary about being able to transform Japan's venture culture, a necessity for funding Japan's innovative technologies and medicines
Craig Venter Wants To Extend Your Life (And Own Your Data)
The onetime Celera CEO says his new attempt to centralize biological information into a massive database could lead to breakthroughs that extend the human life span. Behind that bold goal is a more mundane data-licensing strategy that, although not splashy, could still improve medicine.